AOD 9604 rejuvenates damaged tissue at the cellular level, it is highly possible that it can offer benefits beyond fat loss, and it could be especially valuable for older adults or athletic individuals

External resources PubMed - Search for "AOD 9604" or "tirzepatide" to access original research papers, systematic reviews, and clinical trial data from peer-reviewed journals ClinicalTrials.gov - Official registry of all ongoing and completed tirzepatide clinical trials including the full SURMOUNT and SURPASS programs FDA Drug Safety and Availability - Official safety communications, prescribing information, and regulatory updates for Mounjaro and Zepbound (tirzepatide) New England Journal of Medicine - Published the primary SURMOUNT-1 trial results and other landmark tirzepatide studies The Obesity Society - Evidence-based clinical guidelines and educational resources on pharmacological approaches to obesity management SeekPeptides provides calculators, protocol guides, and comparison tools that help users work through exactly these kinds of decisions with data rather than guesswork
Separation by time of day prevents problematic interactions
Reconstituting AOD 9604, a synthetic peptide fragment based on human growth hormone (hGH), is a critical step in laboratory research to ensure the accuracy and effectiveness of experimental results
This treatment option has a good reputation and some additional benefits